Lb Pharmaceuticals (LBRX) Non-Current Assets (2024 - 2026)

Lb Pharmaceuticals' Non-Current Assets history runs 3 years deep, the most recent figure standing at $4.4 million for Q1 2026.

• In Q1 2026, Non-Current Assets changed N/A year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $17.9 million (changed N/A YoY), while the FY2025 annual figure was $4.5 million, down 3.29% from the prior year.
• Non-Current Assets for Q1 2026 stood at $4.4 million, down from $4.5 million in the prior quarter.
• The five-year high for Non-Current Assets was $4.7 million in Q4 2024, with the low at $4.3 million in Q3 2025.
• The 3-year median for Non-Current Assets is $4.5 million (2025), against an average of $4.5 million.
• Peak annual rise in Non-Current Assets reached 3.29% in 2025, while the deepest fall reached 3.29% in 2025.
• Lb Pharmaceuticals' Non-Current Assets stood at $4.7 million in 2024, then dropped by 3.29% to $4.5 million in 2025, then retreated by 2.09% to $4.4 million in 2026.
• Business Quant data shows LBRX's Non-Current Assets at $4.4 million in Q1 2026, $4.5 million in Q4 2025, and $4.3 million in Q3 2025.